NDC 80425-0171-01 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0171
- Requested NDC
- 80425-0171-01
- Package NDCs from labels
- 80425-0171-3, 80425-0171-2, 80425-0171-1, 80425-0171-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0171-1 | Methocarbamol | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 8 | |
| 80425-0171-2 | Methocarbamol | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 8 | |
| 80425-0171-3 | Methocarbamol | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0171 | METHOCARBAMOL TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 8 | Current NDC, Legacy NDC, 3 package rows | 20250101_c9600cc9-7e27-6e19-e053-2995a90ab024.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0171-1 | EA - Each | 80425-0171 | cdc53f27-e0d3-4ffb-8af5-d419758d22bc | 1 | 2023-06-06 |
| 80425-0171-2 | EA - Each | 80425-0171 | 04ca45d9-2d21-4e99-8b9a-247d01ab4b7b | 1 | 2023-06-06 |
| 80425-0171-3 | EA - Each | 80425-0171 | afb9cb2e-d86c-48b1-bb44-f5928747d6fe | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | 9357672f-5d4d-40f5-a304-e0c34e174dc3 | 2025-06-09 | Warnings, Adverse reactions | ANDA208507 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | 43ea5baa-4200-47ff-8819-44c802cba977 | 2025-06-02 | Warnings, Adverse reactions | 197943 125OD7737X |
| METHOCARBAMOL | METHOCARBAMOL | Preferred Pharmaceuticals Inc. | 5a48be27-5069-40f3-85de-86f248ae232f | 2025-06-02 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | GENTEX PHARMA, LLC | 35c044a6-90c0-55f8-e063-6294a90aad48 | 2025-05-22 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Preferred Pharmaceuticals Inc. | 9169399e-bca1-4c44-9a93-886f3650e44d | 2025-05-19 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol Tablets, USP, 750 mg | METHOCARBAMOL | Bryant Ranch Prepack | 3d686023-a4a2-4dae-8bfb-1f6b01ca24f0 | 2025-05-05 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Preferred Pharmaceuticals Inc. | 38d8b457-0c0f-45cb-bf90-965c5a01b198 | 2025-04-23 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | 2a99a422-6bad-4316-90bc-e7c2d1e3fb53 | 2025-04-08 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Somerset Therapeutics, LLC | 68dd9c24-4d41-48be-9f54-fceb787bb443 | 2025-03-22 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Trifluent Pharma LLC | de2e3af9-03ab-4dc8-b480-6866474ad1bd | 2025-03-03 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Preferred Pharmaceuticals Inc. | eed9ebd1-c243-4e82-bf4e-5fec370e722e | 2025-02-10 | Warnings, Adverse reactions | 197943 125OD7737X |
| methocarbamol | METHOCARBAMOL | FH2 PHARMA LLC | 1dd56e3d-7ca7-1443-e063-6294a90a13c5 | 2025-02-06 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Coupler LLC | 2cee3893-70b7-6c2c-e063-6394a90aa79a | 2025-01-30 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Advanced Rx of Tennessee, LLC | 2cf76cdc-820d-1c5b-e063-6294a90a35aa | 2025-01-30 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Asclemed USA, Inc. | edbcf8c6-0df8-4e72-885b-16d378f06c7b | 2025-01-28 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Redpharm Drug, Inc. | 09d22ef9-a472-4db9-e063-6394a90a8870 | 2025-01-23 | Warnings, Adverse reactions | 197943 125OD7737X |
| METHOCARBAMOL | METHOCARBAMOL | DirectRx | ceb428e0-d6e4-57b7-e053-2995a90afcda | 2025-01-20 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Advanced Rx of Tennessee, LLC | afc9d84d-c8dd-05c0-e053-2a95a90a22a2 | 2024-12-31 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Advanced Rx of Tennessee, LLC | af73ae4b-bcf5-2e21-e053-2a95a90a2dce | 2024-12-31 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Advanced Rx Pharmacy of Tennessee, LLC | c06c4a63-491c-baa2-e053-2a95a90a09ff | 2024-12-31 | Warnings, Adverse reactions | ANDA208507 197943 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.